These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 2300087)

  • 1. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Goodman PJ; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
    N Engl J Med; 1990 Feb; 322(6):352-8. PubMed ID: 2300087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH; Veeder MH; Mailliard JA
    Ann Intern Med; 1995 Mar; 122(5):321-6. PubMed ID: 7847642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
    J Clin Oncol; 1995 Dec; 13(12):2936-43. PubMed ID: 8523058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.
    Grem JL
    Oncology (Williston Park); 1991 Mar; 5(3):63-70, 73; discussion 73-4. PubMed ID: 1829947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does adjuvant therapy work in colon cancer?
    Mayer RJ
    N Engl J Med; 1990 Feb; 322(6):399-401. PubMed ID: 2300092
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
    Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
    J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
    Laurie JA; Moertel CG; Fleming TR; Wieand HS; Leigh JE; Rubin J; McCormack GW; Gerstner JB; Krook JE; Malliard J
    J Clin Oncol; 1989 Oct; 7(10):1447-56. PubMed ID: 2778478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin.
    Dencausse Y; Hartung G; Sturm J; Kopp-Schneider A; Hagmüller E; Wojatschek C; Lindemann H; Fritze D; Queisser W
    Onkologie; 2002 Oct; 25(5):426-30. PubMed ID: 12415196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
    Cascinu S; Catalano V; Piga A; Mattioli R; Marcellini M; Pancotti A; Bascioni R; Torresi U; Silva RR; Pieroni V; Giorgi F; Catalano G; Cellerino R
    Cancer Invest; 2003; 21(5):701-7. PubMed ID: 14628428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole.
    Au E; Ang PT; Seow-Choen F; Soo KC; Low CH; Chng HC; Ng BK
    Ann Acad Med Singap; 1998 Sep; 27(5):733-7. PubMed ID: 9919352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma.
    Smith RD; Hall J; Gurney H; Harnett PR
    Med J Aust; 1993 Mar; 158(5):319-22. PubMed ID: 8474372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
    Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
    J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
    Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
    Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole with fluorouracil for colon cancer.
    Med Lett Drugs Ther; 1989 Oct; 31(802):89-90. PubMed ID: 2674639
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.